The FDA and CDC found bacteria in three batches of preservative-free betamethasone and in a single batch of cardioplegia solution. The test results reinforce the lack of sterility in products manufactured by NECC and that healthcare providers should not use any of its products.
More Articles on Anesthesia:
All Ameridose Products Recalled as Sterility Precaution
Children Less Stressed Before Anesthesia Induction After Watching Videos
Report on Compounding Pharmacies by Congressman Shows Regulations Gaps
Register to Attend Webinar
Presenters:
Joel Ray, COL, USAF, NC, MSN, RN, NEA-BC, Laudio and StaffGarden by Ascend Learning|Larissa Africa, MBA, RN, CENP, FAONL, FAAN, StaffGarden by Ascend Learning|Alicia Potolsky, DNP, RN, NE-BC, DipACLM, El Camino Health|Julie Balluck, DNP, RN, NEA-BC, Texas Health Resources
Next Up in Legal & Regulatory Issues
-
A federal judge on Sept. 14 blocked a rule that would cap J-1 and other visas at four years, one…
-
Nashville, Tenn.-based HCA Healthcare completed its acquisition of The College of Health Care Professions on Sept. 15. HCA shared plans…
-
A federal judge has dismissed Ballad Health’s lawsuit accusing UnitedHealth Group of denying and underpaying Medicare Advantage claims, ruling the…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
